scorecardresearch
Add as a preferred source on Google
Saturday, April 11, 2026
TopicLenacapavir

Topic: Lenacapavir

HIV prevention jab in India soon at fraction of US cost? 2 drugmakers set to roll out generics

Sumi Sukanya Dutta -
Year's supply of injectable to cost Rs 3,549, compared to over Rs 17 lakh in US. Powerful alternative to daily oral PrEP, will overcome issues of adherence, stigma, daily access to pills.

Why Indian patients groups are opposing patent requests for blockbuster HIV drug lenacapavir

Sumi Sukanya Dutta -
Granting patents to US firm Gilead Sciences for lenacapavir could hinder global efforts to end AIDS & restrict access to affordable generics in India, warn civil society organisations.

On Camera

YourTurn

Opinion

What can be expected from the ongoing talks in Islamabad? Odds of resolution remain slim

Swasti Rao -
The initial ceasefire functioned less as a resolution and more as a pause—an opportunity for both sides to recalibrate, while claiming victory.

Pig politicisation isn’t unique to Delhi’s Tri Nagar. It’s a worldwide anti-Muslim strategy

Tamil Nadu’s elections are fought on delivery—ideology appears only when needed

Economy

India bond yields rise as RBI moves to drain liquidity, lift overnight rates

Bloomberg News -
New Delhi: India’s sovereign bond yields rose after the central bank announced its first step this year to drain cash from the banking system,...

Defence

Army promotes Col Purohit, acquitted in 2008 Malegaon blast case, to Brigadier; to not retire yet

Snehesh Alex Philip -
This means he will serve Indian Army for a minimum of another 2 years as Brigadier, unless he picks up the next rank of Major General.

National Interest

China insulated itself against energy shocks. India is ‘all talk, no walk’

Shekhar Gupta -
China patiently invested capital, skill and technology in coal gasification. Unlike it, we won’t move from words to action. As crude prices decline, we lose interest.

Follow us

Copyright © 2025 Printline Media Pvt. Ltd. All rights reserved.